Search - tctmd.com

Displaying 361 - 380 of 510

Sort: Relevancy | Date

Presentation TVT 2023

Position 1: SAVR With Root Enlargement

Presenter: Bo Yang

June 08, 2023

Presentation TVT 2023

Patient-Prosthesis Mismatch (PPM) Using Dimensionless Index (DI); Choosing Self Expandable Versus Balloon Expandable TAVR Using the Current PPM Charts

Presenter: Hirva Vyas

June 08, 2023

Presentation TVT 2023

Transcatheter Aortic and Mitral Valve in Valve Implantations Inside Failed Porcine Bioprosthetic Valves

Presenter: Danny Dvir

June 08, 2023

Presentation TVT 2023

Clinical Implications of Prosthesis-Patient Mismatch and High Residual Gradients After AVR

Presenter: Howard Herrmann

June 08, 2023

Presentation TVT 2023

SPOTLIGHT INNOVATION LECTURE: TAVR in Aortic Regurgitation: A Different Disease, A Different Valve!

Presenter: Raj Makkar

June 08, 2023

Presentation TVT 2023

Comparison of Self-Expanding and Balloon-Expandable Valves For Valve-In-Valve Transcatheter Aortic Valve Replacement

Presenter: Danial Ahmad

June 08, 2023

Presentation TVT 2023

Position 2: Echo Overestimates Bioprosthetic Valve Gradients Following TAVR. Always Confirm With Invasive Assessment

Presenter: David Wood

June 08, 2023

Presentation TVT 2023

Position 1: Echo First and Only for Identification of Bioprosthetic Valve Dysfunction Following TAVR

Presenter: Philippe Pibarot

June 08, 2023

Presentation TVT 2023

First-in-Human XEMED TAVR Implant: An Ultra-Low Profile Modular TAVR System

Presenter: Eberhard Grube

June 08, 2023

Presentation TVT 2023

Valve-In-Valve Transcatheter Aortic Valve Implantation in Failed Stentless Bioprostheses: Results From Polish Nationwide Registry

Presenter: Maciej Mazurek

June 08, 2023

Presentation TVT 2023

DurAVR™ THV: The First-In-Class Biomimetic TAVR to Restore Normal Aortic Flow Hemodynamics-FIH Study Results

Presenter: Christopher Meduri

June 08, 2023

Presentation TVT 2023

Featured TAVR Innovation: Treatment of Infective Endocarditis (IE) Using Drug-Eluting Transcatheter Valve Replacement (DE - TAVR)

Presenter: Alexander Lauten

June 08, 2023

Presentation TVT 2023

SPOTLIGHT INNOVATION LECTURE: TAVR Innovation Priorities: From Short Term Outcomes to Lifetime Management

Presenter: Isaac George

June 08, 2023

Presentation TVT 2023

Comparison of Current Generation Balloon-Expandable Versus Self-Expanding Transcatheter Aortic Valve Replacement in Patients With a Horizontal Aorta: A Propensity-Matched Study

Presenter: Fahad Ahmed

June 08, 2023

Presentation TVT 2023

Stroke after TAVR: To Protect or Not to Protect?

Presenter: John Forrest

June 08, 2023

Presentation TVT 2023

Clinical Data for the ACURATE Platform

Presenter: Ole De Backer

June 08, 2023

Presentation TVT 2023

Lifetime Management of Aortic Stenosis: The Importance of Choosing the First Valve

Presenter: Isaac George

June 08, 2023

Presentation TVT 2023

Patients With AS and Atrial Fibrillation: Updates on the WATCH-TAVR Trial

Presenter: Brian Whisenant

June 08, 2023

Presentation TVT 2023

Considerations for Physiologic Testing to Assess CAD Severity in Patients With AS

Presenter: Rahul Sharma

June 08, 2023

Presentation TVT 2023

Imaging for Standard TAVI: CT commissural alignment and coronary access

Presenter: Nicolo Piazza

June 08, 2023

Advertisement

Position 1: SAVR With Root Enlargement

Patient-Prosthesis Mismatch (PPM) Using Dimensionless Index (DI); Choosing Self Expandable Versus Balloon Expandable TAVR Using the Current PPM Charts

Transcatheter Aortic and Mitral Valve in Valve Implantations Inside Failed Porcine Bioprosthetic Valves

Clinical Implications of Prosthesis-Patient Mismatch and High Residual Gradients After AVR

SPOTLIGHT INNOVATION LECTURE: TAVR in Aortic Regurgitation: A Different Disease, A Different Valve!

Comparison of Self-Expanding and Balloon-Expandable Valves For Valve-In-Valve Transcatheter Aortic Valve Replacement

Position 2: Echo Overestimates Bioprosthetic Valve Gradients Following TAVR. Always Confirm With Invasive Assessment

Position 1: Echo First and Only for Identification of Bioprosthetic Valve Dysfunction Following TAVR

First-in-Human XEMED TAVR Implant: An Ultra-Low Profile Modular TAVR System

Valve-In-Valve Transcatheter Aortic Valve Implantation in Failed Stentless Bioprostheses: Results From Polish Nationwide Registry

DurAVR™ THV: The First-In-Class Biomimetic TAVR to Restore Normal Aortic Flow Hemodynamics-FIH Study Results

Featured TAVR Innovation: Treatment of Infective Endocarditis (IE) Using Drug-Eluting Transcatheter Valve Replacement (DE - TAVR)

SPOTLIGHT INNOVATION LECTURE: TAVR Innovation Priorities: From Short Term Outcomes to Lifetime Management

Comparison of Current Generation Balloon-Expandable Versus Self-Expanding Transcatheter Aortic Valve Replacement in Patients With a Horizontal Aorta: A Propensity-Matched Study

Stroke after TAVR: To Protect or Not to Protect?

Clinical Data for the ACURATE Platform

Lifetime Management of Aortic Stenosis: The Importance of Choosing the First Valve

Patients With AS and Atrial Fibrillation: Updates on the WATCH-TAVR Trial

Considerations for Physiologic Testing to Assess CAD Severity in Patients With AS

Imaging for Standard TAVI: CT commissural alignment and coronary access

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content